Skip to menu Skip to content Skip to footer
Dr Andrew Mallett
Dr

Andrew Mallett

Email: 

Overview

Background

Professor Andrew Mallett is a Nephrologist with a special interest in inherited kidney disease and nephrogenetics. After graduating from James Cook University (MBBS, 2006) he completed physician training at Mackay Base Hospital, Royal Brisbane and Women's Hospital and Princess Alexandra Hospital (MMed USyd, 2009; AFRACMA 2011; FRACP 2013; FASN 2016). Professor Mallett has undertaken a Churchill Fellowship and been a recurrent Visiting Fellow at Addenbrooke's Hospital (Cambridge, UK) and the Cambridge Institute for Medical Research (University of Cambridge). He has completed a PhD in nephrogenetics collaborating nationally and internationally, and is a Consultant Nephrologist at RBWH, co-leading the statewide Queensland Conjoint Renal Genetics Service. Professor Mallett is National Director of KidGen, the AGHA Renal Genetics Rare Disease Flagship.

Availability

Dr Andrew Mallett is:
Available for supervision
Media expert

Works

Search Professor Andrew Mallett’s works on UQ eSpace

212 works between 2012 and 2025

81 - 100 of 212 works

2023

Journal Article

Do educational interventions improve prescribing skills of medical students compared to no additional learning? A systematic review

Mokrzecki, Sophie M., Mallett, Andrew, Sen Gupta, Tarun, Perks, Stephen and Pain, Tilley (2023). Do educational interventions improve prescribing skills of medical students compared to no additional learning? A systematic review. Medical Education Online, 28 (1) 2259166. doi: 10.1080/10872981.2023.2259166

Do educational interventions improve prescribing skills of medical students compared to no additional learning? A systematic review

2023

Conference Publication

A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials

Stanley, I., Palma, A., Viecelli, A., Johnson. D., Hawley, C., Staatz, C. and Mallett, A. (2023). A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials. Asian Pacific Society of Dialysis Access (APSDA) Conference, Cairns, QLD Australia, 22-24th October 2023. HOBOKEN: WILEY.

A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials

2023

Journal Article

From the internet to the COVID-19 pandemic: how technological advances and a tumultuous world have changed scientific publishing and meetings

Torreggiani, Massimo, Piccoli, Giorgina Barbara and Mallett, Andrew (2023). From the internet to the COVID-19 pandemic: how technological advances and a tumultuous world have changed scientific publishing and meetings. Journal of Nephrology, 36 (8), 2165-2167. doi: 10.1007/s40620-023-01740-7

From the internet to the COVID-19 pandemic: how technological advances and a tumultuous world have changed scientific publishing and meetings

2022

Journal Article

The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study

Mallett, Andrew, Kearey, Phoebe Jane, Cameron, Anne, Healy, Helen G., Denaro, Charles, Thomas, Mark, Lee, Vincent W., Stark, Samantha Louise, Fuller, Maria, Wang, Zaimin and Hoy, Wendy E. (2022). The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study. BMC Nephrology, 23 (1) 169, 169. doi: 10.1186/s12882-022-02805-8

The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study

2022

Journal Article

Characterising patients and clinician experiences in comprehensive conservative care for kidney failure in northern Queensland

Al Maraee, Gheed, Vangaveti, Venkat and Mallett, Andrew (2022). Characterising patients and clinician experiences in comprehensive conservative care for kidney failure in northern Queensland. Internal Medicine Journal, 53 (10), 1819-1825. doi: 10.1111/imj.15977

Characterising patients and clinician experiences in comprehensive conservative care for kidney failure in northern Queensland

2022

Conference Publication

Nedosiran in Patients With Primary Hyperoxaluria 1: Interim Results From an Extension Trial (PHYOX3)

Lieske, John C., Ariceta, Gema, Baum, Michelle A., Belostotsky, Vladimir, Cappoli, Andrea, Cochat, Pierre, Forbes, Thomas A., Groothoff, Jaap, Hamamoto, Shuzo, Hoppe, Bernd, Mallett, Andrew J., Torres, Armando, Satoh, Hiroyuki, Toenshoff, Burkhard, Karafilidis, John and Moochhala, Shabbir H. (2022). Nedosiran in Patients With Primary Hyperoxaluria 1: Interim Results From an Extension Trial (PHYOX3). Kidney Week, Philadelphia, PA United States, 1-5 November 2023. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1681/asn.20223311s111b

Nedosiran in Patients With Primary Hyperoxaluria 1: Interim Results From an Extension Trial (PHYOX3)

2022

Journal Article

Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future

Mallett, Andrew J. (2022). Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future. Current Opinion in Nephrology and Hypertension, 31 (6), 541-547. doi: 10.1097/MNH.0000000000000836

Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future

2022

Journal Article

Theory designed strategies to support implementation of genomics in nephrology

Kansal, Arushi, Quinlan, Catherine, Stark, Zornitza, Kerr, Peter G., Mallett, Andrew J., Lakshmanan, Chandni, Best, Stephanie and Jayasinghe, Kushani (2022). Theory designed strategies to support implementation of genomics in nephrology. Genes, 13 (10) 1919, 1-14. doi: 10.3390/genes13101919

Theory designed strategies to support implementation of genomics in nephrology

2022

Journal Article

Cellular milieu in clear cell renal cell carcinoma

Raghubar, Arti M., Roberts, Matthew J., Wood, Simon, Healy, Helen G., Kassianos, Andrew J. and Mallett, Andrew J. (2022). Cellular milieu in clear cell renal cell carcinoma. Frontiers in Oncology, 12 943583, 1-10. doi: 10.3389/fonc.2022.943583

Cellular milieu in clear cell renal cell carcinoma

2022

Journal Article

Participant choice towards receiving potential additional findings in an Australian nephrology research genomics study

O’Shea, Rosie, Wood, Alasdair, Patel, Chirag, McCarthy, Hugh J., Mallawaarachchi, Amali, Quinlan, Catherine, Simons, Cas, Stark, Zornitza and Mallett, Andrew J. (2022). Participant choice towards receiving potential additional findings in an Australian nephrology research genomics study. Genes, 13 (10) 1804, 1-7. doi: 10.3390/genes13101804

Participant choice towards receiving potential additional findings in an Australian nephrology research genomics study

2022

Conference Publication

Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients?

Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C. E. (2022). Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients?. Australian and New Zealand Society of Nephrology meeting, Sydney, NSW Australia, October 2022.

Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients?

2022

Conference Publication

Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients?

Scuderi, Carla, Parker, Suzanne, Jacks, Margaret, John, George, McWhinney, Brett, Ungerer, Jacobus, Mallett, Andrew, Healy, Helen, Roberts, Jason and Staatz, Christine (2022). Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients?. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, NSW Australia, 17-19 October 2022. Richmond, VIC Australia: John Wiley & Sons.

Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients?

2022

Journal Article

Chronic kidney disease in public renal practices in Queensland, Australia, 2011‐2018

Hoy, Wendy E., Wang, Zaimin, Zhang, Jianzhen, Diwan, Vishal, Cameron, Anne, Venuthurupalli, Sree K., Fassett, Robert G., Chan, Samuel, Healy, Helen G., Tan, Ken‐Soon, Baer, Richard, Mallett, Andrew J., Gray, Nicholas, Mantha, Murty, Cherian, Roy, Mutatiri, Clyson, Madhan, Krishan, Kan, George, Mitchell, Geoffrey, Hossain, Shahadat, Wu, Danielle, Han, Thin, Kark, Adrian, Titus, Thomas, Ranganathan, Dwarakanatan, Bonner, Ann, Govindarajulu, Sridevi and the NHMRC CKD. CRE and the CKD.QLD Collaborative. (2022). Chronic kidney disease in public renal practices in Queensland, Australia, 2011‐2018. Nephrology, 27 (12), 934-944. doi: 10.1111/nep.14111

Chronic kidney disease in public renal practices in Queensland, Australia, 2011‐2018

2022

Journal Article

Spatially resolved transcriptomes of mammalian kidneys illustrate the molecular complexity and interactions of functional nephron segments

Raghubar, Arti M., Pham, Duy T., Tan, Xiao, Grice, Laura F., Crawford, Joanna, Lam, Pui Yeng, Andersen, Stacey B., Yoon, Sohye, Teoh, Siok Min, Matigian, Nicholas A., Stewart, Anne, Francis, Leo, Ng, Monica S. Y., Healy, Helen G., Combes, Alexander N., Kassianos, Andrew J., Nguyen, Quan and Mallett, Andrew J. (2022). Spatially resolved transcriptomes of mammalian kidneys illustrate the molecular complexity and interactions of functional nephron segments. Frontiers in Medicine, 9 873923, 873923. doi: 10.3389/fmed.2022.873923

Spatially resolved transcriptomes of mammalian kidneys illustrate the molecular complexity and interactions of functional nephron segments

2022

Journal Article

Determining the association between the type of intervention for ischaemic heart disease and mortality and morbidity in patients with chronic kidney disease

Jeyaruban, Andrew, Hoy, Wendy, Cameron, Anne L., Healy, Helen G., Wang, Zaimin, Zhang, Jenny and Mallett, Andrew (2022). Determining the association between the type of intervention for ischaemic heart disease and mortality and morbidity in patients with chronic kidney disease. Internal Medicine Journal, 52 (7), 1190-1195. doi: 10.1111/imj.15297

Determining the association between the type of intervention for ischaemic heart disease and mortality and morbidity in patients with chronic kidney disease

2022

Journal Article

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Köttgen, Anna, Cornec-Le Gall, Emilie, Halbritter, Jan, Kiryluk, Krzysztof, Mallett, Andrew J., Parekh, Rulan S., Rasouly, Hila Milo, Sampson, Matthew G., Tin, Adrienne, Antignac, Corinne, Ars, Elisabet, Bergmann, Carsten, Bleyer, Anthony J., Bockenhauer, Detlef, Devuyst, Olivier, Florez, Jose C., Fowler, Kevin J., Franceschini, Nora, Fukagawa, Masafumi, Gale, Daniel P., Gbadegesin, Rasheed A., Goldstein, David B., Grams, Morgan E., Greka, Anna, Gross, Oliver, Guay-Woodford, Lisa M., Harris, Peter C., Hoefele, Julia, Hung, Adriana M. ... KDIGO Conference Participants (2022). Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 101 (6), 1126-1141. doi: 10.1016/j.kint.2022.03.019

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2022

Journal Article

The HIDDEN Protocol: An Australian prospective cohort study to determine the utility of whole genome sequencing in kidney failure of unknown aetiology

Soraru, Jacqueline, Jahan, Sadia, Quinlan, Catherine, Simons, Cas, Wardrop, Louise, O’Shea, Rosie, Wood, Alasdair, Mallawaarachchi, Amali, Patel, Chirag, Stark, Zornitza and Mallett, Andrew John (2022). The HIDDEN Protocol: An Australian prospective cohort study to determine the utility of whole genome sequencing in kidney failure of unknown aetiology. Frontiers in Medicine, 9 891223, 1-6. doi: 10.3389/fmed.2022.891223

The HIDDEN Protocol: An Australian prospective cohort study to determine the utility of whole genome sequencing in kidney failure of unknown aetiology

2022

Journal Article

The evolving role of diagnostic genomics in kidney transplantation

Soraru, Jacqueline, Chakera, Aron, Isbel, Nikky, Mallawaarachichi, Amali, Rogers, Natasha, Trnka, Peter, Patel, Chirag and Mallett, Andrew J. (2022). The evolving role of diagnostic genomics in kidney transplantation. Kidney International Reports, 7 (8), 1758-1771. doi: 10.1016/j.ekir.2022.05.019

The evolving role of diagnostic genomics in kidney transplantation

2022

Journal Article

A clinical approach to tubulopathies in children and young adults

Kermond, Rachael, Mallett, Andrew and McCarthy, Hugh (2022). A clinical approach to tubulopathies in children and young adults. Pediatric Nephrology, 38 (3), 1-12. doi: 10.1007/s00467-022-05606-1

A clinical approach to tubulopathies in children and young adults

2022

Journal Article

The heritability of kidney function using an older Australian twin population

Jefferis, Julia, Pelecanos, Anita, Catts, Vibeke and Mallett, Andrew (2022). The heritability of kidney function using an older Australian twin population. Kidney International Reports, 7 (8), 1819-1830. doi: 10.1016/j.ekir.2022.05.012

The heritability of kidney function using an older Australian twin population

Funding

Current funding

  • 2025
    KidGen Collaborative: Effective, efficient and equitable care of patients with genetic kidney disease through a national network of multidisciplinary clinics and education programs
    Commonwealth Department of Health
    Open grant
  • 2023 - 2028
    IMPEDE-PKD: Metformin to protect kidney function in polycystic kidney disease
    University of Otago
    Open grant
  • 2022 - 2025
    Genomic Approaches to Kidney Health and Disease
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2020 - 2027
    Implementation of Metformin theraPy to Ease DEcline of kidney function in PKD - the IMPEDE-PKD trial
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2021 - 2022
    Rab GTPase regulation in Ciliogenesis and Polycystic Kidney Disease
    PKD Foundation of Australia Limited
    Open grant
  • 2020 - 2023
    KidGen Clinics, Education, Data and Research (KidGen CEDAR): Improving Care and Outcomes of Australians with Genetic Kidney Disease
    Commonwealth Department of Health
    Open grant
  • 2020 - 2021
    Applying Spatial Transcriptomics to Discover Kidney Disease Pathways and Optimize Clinical Kidney Biopsy Assessment
    Metro North Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018
    The HIDDEN Study (wHole genome Investigation to iDentify unDEtected Nephropathies) - Applying Genomics to Understand Unexplained End Stage Kidney Disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2016 - 2019
    Applying functional genomics to kidney disease (NHMRC Project Grant Administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant

Supervision

Availability

Dr Andrew Mallett is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Dr Andrew Mallett directly for media enquiries about:

  • Alport Syndrome
  • clinical genomic
  • genetic kidney disease
  • genetics
  • genomics
  • inherited kidney disease
  • kidney
  • kidney disease
  • kidney genetics
  • nephrology
  • polycystic kidney disease
  • renal genetics

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au